descriptive
Analysis v1
39
0
Half of the 32 people with type 2 diabetes who took oral semaglutide for 6 months lost at least 5% of their body weight.
Scientific Claim
In 32 adults with type 2 diabetes, oral semaglutide use over 26 weeks was associated with at least 5% body weight loss in 50% of patients.
Original Statement
“At T6, 16 patients (50%) were classified as R (7 men and 12 women).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study is observational with no control group, so causation cannot be established. The use of 'associated with' correctly reflects the evidence.
Evidence from Studies
Supporting (1)
39
Contradicting (0)
0
No contradicting evidence found